The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma
- 1 September 2002
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 12 (5) , 438-442
- https://doi.org/10.1046/j.1525-1438.2002.01171.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Preoperative CA‐125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancerActa Obstetricia et Gynecologica Scandinavica, 2001
- CA125 production by the peritoneum: in-vitro and in-vivo studiesHuman Reproduction, 2000
- Ovarian Volume Related to AgeGynecologic Oncology, 2000
- Preoperative Prediction of Optimal Resectability in Advanced Ovarian Cancer Using CA-125Gynecologic Oncology, 2000
- Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosisAmerican Journal of Gastroenterology, 1999
- CA 125: fundamental and clinical aspectsSeminars in Cancer Biology, 1999
- Human Peritoneal Mesothelial Cells Are More Potent Than Ovarian Cancer Cells in Producing Tumor Marker CA-125Gynecologic Oncology, 1996
- CA 125 (ovarian tumour-associated antigen) in ascitic liver diseasesClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981